In the News

In the News

High Court Considers Drug Sales Reps' OT Status

  • Law360.com
Law360.com

In an article on the U.S. Supreme Court oral arguments in Christopher v. SmithKline, Littler’s Tammy McCutchen provides perspective on the Justices’ line of questioning on whether a proposed class of reps is entitled to overtime pay. McCutchen, who filed an amicus brief in support of GlaxoSmithKline on behalf of the National Federation of Independent Business, notes that “there were no clear positions along political or philosophical lines.”

View Article (subscription required)

Information contained in this publication is intended for informational purposes only and does not constitute legal advice or opinion, nor is it a substitute for the professional judgment of an attorney.

Let us know how we can help you navigate your particular workplace legal issues.